about
Centrosome dysfunction contributes to chromosome instability, chromoanagenesis, and genome reprograming in cancerCDK2 Inhibition Causes Anaphase Catastrophe in Lung Cancer through the Centrosomal Protein CP110Drugging the addict: non-oncogene addiction as a target for cancer therapyA screen for selective killing of cells with chromosomal instability induced by a spindle checkpoint defectInduction of robust de novo centrosome amplification, high-grade spindle multipolarity and metaphase catastrophe: a novel chemotherapeutic approach.New Insights in the Cytogenetic Practice: Karyotypic Chaos, Non-Clonal Chromosomal Alterations and Chromosomal Instability in Human Cancer and Therapy ResponseA phenanthrene derived PARP inhibitor is an extra-centrosomes de-clustering agent exclusively eradicating human cancer cellsRegulation of mitotic cytoskeleton dynamics and cytokinesis by integrin-linked kinase in retinoblastoma cells.The circadian clock gene BMAL1 is a novel therapeutic target for malignant pleural mesothelioma.Response to inhibition of smoothened in diverse epithelial cancer cells that lack smoothened or patched 1 mutations.Cell death associated with abnormal mitosis observed by confocal imaging in live cancer cells.The Consequences of Chromosome Segregation Errors in Mitosis and Meiosis.Let's huddle to prevent a muddle: centrosome declustering as an attractive anticancer strategy.The centrosome as potential target for cancer therapy and prevention.Mitotic spindle multipolarity without centrosome amplification.Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer.Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin-Dependent Kinases 1 and 2.Integrin-linked kinase regulates senescence in an Rb-dependent manner in cancer cell lines.Targeted TPX2 increases chromosome missegregation and suppresses tumor cell growth in human prostate cancer.Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers.
P2860
Q21129300-D0171918-7B3F-452D-8BE0-C71EA216D56AQ27347950-5EAA2AAE-D23A-4B07-8773-788A88A3841DQ28079559-D9F356F1-B0F5-4BBE-8C40-4DC1C8DD116AQ28484384-2C1B4D58-D1EF-4606-9060-49BB0528BD61Q30523067-89815A25-7F6A-481C-BE87-702E3336F9EFQ33836777-D9FEB01D-8685-4474-BE6D-61E7B4ED09E5Q34029054-12A707EC-FF97-4783-925A-24C3ED80A727Q35184072-81AD6503-B60D-4AEA-90E8-E6FF935BA77EQ36342061-2E02807D-354A-4501-B162-36F859C35C5CQ36643409-2108C4F4-6EBE-4619-96DA-5F4994E42A2CQ37376022-7F46178F-2BA4-4D11-BA5D-CADBF18F81C4Q37728190-5C87F945-7AB4-4EB8-A4FF-71E99FE0E52AQ38015243-B002F53B-320B-4BBB-AF1B-C681B9C3CA41Q38051759-D80D7675-6AEB-4AF8-AF7E-B0E6BC461E94Q38219034-99113381-F47B-48A1-A9A0-45C8A004BA9CQ38708974-7F2FF48C-E4C8-4A04-8A93-D46E8FB0F766Q38734002-9ED95A78-7226-483B-BBD5-5ED1D05A662AQ38852924-80D80BF4-B33E-4F3C-81B7-95AE2192410BQ41097100-B7147781-A504-4ADC-8FE7-ACA06ED07400Q50056269-68626324-2222-4733-9E10-7CC3799A43AA
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Anaphase catastrophe is a target for cancer therapy
@ast
Anaphase catastrophe is a target for cancer therapy
@en
Anaphase catastrophe is a target for cancer therapy
@nl
type
label
Anaphase catastrophe is a target for cancer therapy
@ast
Anaphase catastrophe is a target for cancer therapy
@en
Anaphase catastrophe is a target for cancer therapy
@nl
prefLabel
Anaphase catastrophe is a target for cancer therapy
@ast
Anaphase catastrophe is a target for cancer therapy
@en
Anaphase catastrophe is a target for cancer therapy
@nl
P2093
P2860
P1476
Anaphase catastrophe is a target for cancer therapy
@en
P2093
Ethan Dmitrovsky
Fabrizio Galimberti
Sarah L Thompson
Saranya Ravi
P2860
P304
P356
10.1158/1078-0432.CCR-10-1178
P407
P577
2011-02-02T00:00:00Z